Salih Tagwa A M, Yousef Bashir A, Salih Mohamed A M, Eltom Khalid S
Department of Pharmacology, Faculty of Pharmacy, Sudan International University, Khartoum, Khartoum, 11111, Sudan.
Department of Pharmacology, Faculty of Pharmacy, University of Khartoum, Khartoum, Khartoum, 11111, Sudan.
F1000Res. 2019 Oct 1;8:1708. doi: 10.12688/f1000research.19370.2. eCollection 2019.
Vancomycin is an antibiotic of growing importance in the treatment of hospital-acquired infections; with a particular emphasis on its value in the fight against Methicillin-resistant . Increasing reports of Vancomycin resistance have raised concerns about the effectiveness of this drug. Drug utilization evaluation has an important role in controlling rational use of antibiotics to prevent the emergence of resistance. We conducted a retrospective 6-months study at Jafar Ibn Auf pediatric hospital. Data including patient's demographics, diagnosis, Dosage regimen, and treatment duration were reviewed. The concordance of practice with the Hospital Infection Control Practices Advisory Committee (HICPAC) guidelines and principles of antibiotic therapy was assessed. 127 medical records were reviewed in this study. Sepsis (29%) and Pneumonia (19.6%) were the most common indications. Culture test was requested in 20.5% of patients. Monitoring of serum creatinine was carried in 81.1% of patients. Based on HICPAC guidelines vancomycin was administered appropriately in 67.7% percent of cases. Considering the infusion rate, most of patients with specific order were received vancomycin in 1 hour. The results showed that vancomycin was used empirically without subsequent adjustment of the antimicrobial agent according to culture and sensitivity data and lack of paying enough attention to the infusion rate and serum creatinine monitoring.
万古霉素在医院获得性感染的治疗中愈发重要;尤其强调其在对抗耐甲氧西林菌方面的价值。万古霉素耐药报告的不断增加引发了对该药物有效性的担忧。药物利用评估在控制抗生素合理使用以预防耐药性出现方面发挥着重要作用。我们在贾法尔·伊本·奥夫儿童医院进行了一项为期6个月的回顾性研究。回顾了包括患者人口统计学、诊断、给药方案和治疗时长等数据。评估了实际做法与医院感染控制实践咨询委员会(HICPAC)指南及抗生素治疗原则的一致性。本研究共回顾了127份病历。脓毒症(29%)和肺炎(19.6%)是最常见的适应症。20.5%的患者进行了培养检测。81.1%的患者进行了血清肌酐监测。根据HICPAC指南,67.7%的病例万古霉素使用得当。考虑到输注速率,大多数有特定医嘱的患者在1小时内接受了万古霉素治疗。结果显示,万古霉素在使用时未根据培养和药敏数据对抗菌药物进行后续调整,且对输注速率和血清肌酐监测缺乏足够重视。